Moody's rates Wyeth loans A3

Moody's Investors Service said it assigned a long-term senior debt rating of A3 to Wyeth's $3 billion credit facility due 2012.

The outlook is positive.

Wyeth's A3 rating reflects its strong position in the global pharmaceutical market, its healthy cash flow relative to debt and its strong liquidity, the agency said.

These factors are offset by recent operating challenges including pipeline disappointments and rising exposure to patent expirations from 2010 to 2012, Moody's said.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.